Form 8-K - Current report:
SEC Accession No. 0001213900-25-057898
Filing Date
2025-06-25
Accepted
2025-06-25 17:20:26
Documents
13
Period of Report
2025-06-25
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246859-8k_180life.htm   iXBRL 8-K 32622
  Complete submission text file 0001213900-25-057898.txt   244455

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20250625.xsd EX-101.SCH 3786
3 XBRL DEFINITION FILE atnf-20250625_def.xml EX-101.DEF 26628
4 XBRL LABEL FILE atnf-20250625_lab.xml EX-101.LAB 36679
5 XBRL PRESENTATION FILE atnf-20250625_pre.xml EX-101.PRE 25252
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0246859-8k_180life_htm.xml XML 5828
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 251074537
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)